Pfizer's Head of Clinical Innovation on the Future of Clinical Trials
Add bookmark
There are mounting challenges around the sustainability of clinical trials as the pharmaceutical industry is faced with increasingly complex and expensive trials. But new models and collaberations are emerging, creating new opportunity around ways data is being captured and around the efficacy and safety of new medicines through novel collaberations which will help ensure the sustainability and delivery of new medicines for the patients of the future. Craig Lipset, Head of Innovation at Pfizer, discusses this and Pfizer's vision for Clinical Trials in the future, including their recent transformational creative collaboration models.
Tags:
Clinical Trials
Innovation in Clinical Trials
Craig Lipset
pfizer
Clinical Trials Phase 1
Clinical Trials III
